News Search Results
Sep 22, 2025, 08:44 ET True Indicating: The Innovation-Driven Company Reinventing Sterilization Science
disinfection monitoring products and expert services to medical device manufacturers, healthcare, dental, laboratory service providers, life science, biotechnology companies, industrial, and pharmaceutical manufacturers, The company has over 35 years of combined experience, with a focus on science-based service.
More news about: True Indicating
Sep 22, 2025, 08:30 ET Patient Recruitment Strategies: Fixing the Friction in Trial Enrollment, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Sep 22, 2025, 08:30 ET Biomarker Discovery: Integrating Proteomics and Genomics for Comprehensive Biological Insights, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Sep 22, 2025, 08:30 ET BYOD or Bust: Are Clinical Trials Ready for the Device Revolution? Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Sep 22, 2025, 08:30 ET Enhancing Clinical Trials in Obesity by Integrating Clinical Outcome Assessments and Digital Health Technologies, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Sep 22, 2025, 08:05 ET Cleveland Clinic to Present Final Results of Phase 1 Clinical Trial for Anixa Biosciences' Breast Cancer Vaccine at 2025 San Antonio Breast Cancer Symposium
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that final results from the Phase 1 clinical trial of its breast cancer
More news about: Anixa Biosciences, Inc.
Sep 22, 2025, 08:00 ET Coya Therapeutics Launches the ALSTARS Trial, a Phase 2 Clinical Study to Assess the Efficacy and Safety of COYA 302 in Amyotrophic Lateral Sclerosis
Sept. 22, 2025 /PRNewswire/ -- Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with neurodegenerative disorders, announced today
More news about: Coya Therapeutics, Inc.
Sep 22, 2025, 07:30 ET Palatin Earns €5.5 Million ($6.5 Million) Milestone Payment in Retinal Disease Collaboration with Boehringer Ingelheim
complete clinical trials and submit applications for regulatory approvals, products developed by competing pharmaceutical, biopharmaceutical and biotechnology companies, commercial acceptance of Palatin's products, and other factors discussed in Palatin's periodic filings with the Securities and Exchange
More news about: Palatin Technologies, Inc.
Sep 22, 2025, 00:15 ET First-in-Class Potential! FDA Clears IND Application for LBL-047, an Anti-BDCA2/TACI Bispecific Fusion Protein Developed by Leads Biolabs
(ADCC) and Fc engineering for an extended half-life. About Leads Biolabs Founded in 2012, Leads Biolabs is a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of innovative therapies to address underserved medical needs in oncology,
More news about: Leads Biolabs
Sep 21, 2025, 20:29 ET AusperBio Raises $63 Million in Series B2 Financing to Accelerate Functional Cure Therapies for Chronic Hepatitis B
/PRNewswire/ -- AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a privately held clinical-stage biotechnology company dedicated to advancing targeted oligonucleotide therapies to achieve a functional cure for chronic hepatitis B (CHB), today announced
More news about: AusperBio Therapeutics Inc.
Sep 21, 2025, 20:10 ET Ascletis Announces ASC47 in Combination with Semaglutide Demonstrated Up to 56.2% Greater Relative Reduction in Body Weight in Participants with Obesity Compared to Semaglutide Monotherapy
was four weeks and the follow-up period was six weeks. About Ascletis Pharma Inc. Ascletis Pharma Inc. is a fully integrated biotechnology company focused on the development and commercialization of potential best-in-class and first-in-class therapeutics to treat metabolic diseases.
More news about: Ascletis Pharma Inc.
Sep 20, 2025, 08:00 ET Do you own shares of KBR? Robbins LLP Informs Investors of the Jasper Therapeutics, Inc. Class Action Lawsuit
JSPR) securities between November 30, 2023 and July 3, 2025. Jasper, a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria ("CSU"), Chronic Inducible
More news about: Robbins LLP
Sep 19, 2025, 20:07 ET Stealth BioTherapeutics Announces FDA Accelerated Approval of FORZINITY™ (elamipretide HCl), the First Therapy for Progressive and Life-limiting Ultra-rare Genetic Disease Barth Syndrome
Sept. 19, 2025 /PRNewswire/ -- Stealth BioTherapeutics Inc. (the "Company" or "Stealth"), a commercial-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today announced
More news about: Stealth BioTherapeutics Inc.
Sep 19, 2025, 12:34 ET FDA Greenlights HDT Bio's First-in-Class HDT-321 for the Prevention of Deadly Tick-Borne Disease
Sept. 19, 2025 /PRNewswire/ -- HDT Bio Corporation, a U.S.-based clinical-stage biotechnology company advancing immune-enhancing solutions for global health, biodefense, and oncology, today announced that the U.S. Food and Drug Administration
More news about: HDT Bio Corp.
Sep 19, 2025, 11:01 ET Robot End-Effector Market Is Expected To Reach US$13.76 Billion By 2031 With CAGR Of 14.5% | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Sep 19, 2025, 10:30 ET Optical Transceiver Market Is Projected To Reach US$36.73 Billion By 2031 With CAGR Of 14.2% | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Sep 19, 2025, 10:01 ET SCADA System Market Size Is Projected To Reach US$24.42 Billion By 2031 With A CAGR Of 9.6% | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Sep 19, 2025, 08:30 ET Evommune Presents Full Phase 2 Data for Oral MRGPRX2 Inhibitor EVO756 in Chronic Inducible Urticaria During Late-Breaker at EADV 2025 Congress
Calif., Sept. 19, 2025 /PRNewswire/ -- Evommune, Inc., a clinical-stage biotechnology company discovering and developing innovative therapies that target key drivers of chronic inflammatory diseases, today presented additional positive
More news about: Evommune, Inc
Sep 18, 2025, 20:33 ET AusperBio Completes Enrollment in Two Phase II Clinical Trials of AHB-137 for Chronic Hepatitis B
/PRNewswire/ -- AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a clinical-stage biotechnology company advancing targeted oligonucleotide therapies for chronic hepatitis B (CHB) functional cure, today announced the completion of patient enrollment
More news about: AusperBio Therapeutics Inc.
Sep 18, 2025, 16:00 ET Innocan Pharma Partners With a Sanctuary For Injured Animals to Bring Remedy and Hope with its LPT-CBD injection
/PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce its ongoing collaboration with Freedom Farm, a sanctuary dedicated to rescuing animals that were expelled from
More news about: Innocan Pharma Corporation
Sep 18, 2025, 16:00 ET Innocan Pharma Partners With a Sanctuary For Injured Animals to Bring Remedy and Hope with its LPT-CBD injection
2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce its ongoing collaboration with Freedom Farm, a sanctuary dedicated to rescuing animals that were expelled from
More news about: Innocan Pharma Corporation
Sep 18, 2025, 10:14 ET Global Autonomous Vehicle Market Size & Share to Surpass $658.1 Billion by 2035, Growing at a CAGR 22.19% | Driving the Future of Mobility, Transportation, and Smart Cities
market research reports and actionable intelligence across healthcare, biotechnology, and advanced cell therapies. Our globally recognized insights empower stakeholders to make informed decisions, anticipate trends, and capitalize
More news about: Vantage Market Research
Sep 18, 2025, 10:05 ET nuBioAge's Clinical Longevity Summit Gathers World-Leading Physicians in West Palm Beach to Deliver the First Comprehensive Roadmap for Post-COVID Treatment
symptoms. She brought special guest researcher and chemist, Dr. Simone Cristoni, from ISB: Ion Source and BioTechnology R&D Labs, to introduce breakthrough diagnostics capable of differentiating between vaccine-derived and wild-type spike proteins, paving the
More news about: NUBIOAGE LLC
Sep 18, 2025, 10:01 ET Contract Development and Manufacturing Organization (CDMO) Outsourcing Market Surges to USD 60.3 Billion by 2033, Propelled by 7.3% CAGR - Verified Market Reports®
Assurance ServicesPost-Manufacturing Support ServicesBy End-user Industries PharmaceuticalsBiotechnologyHealthcareCosmetics and Personal CareFood and BeverageBy Scale of Production Small
More news about: Verified Market Reports
Sep 18, 2025, 10:01 ET Cloud Object Storage Market Driven by Rising Data Growth, Scalability Needs, and Enterprise Cloud Adoption Across Key Industry Verticals - Market Research Intellect
Thermostatic Baths Market is categorized based on Application (Pharmaceutical Laboratories, Chemical Research, Biotechnology, Food & Beverage Testing, Environmental Testing, Academic & Educational Labs, Clinical Diagnostics) and Type (Heated Circulating Baths,
More news about: Market Research Intellect